Form 4 for BVS Bioventus Inc.
Accepted 2025-03-14 00:00:00 ET · period of report 2025-03-14 · accession 0001578563-25-000177 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-03-14 | 2025-03-14 | BVS | CHURCH KATRINA J | SVP, CCO | M - OptEx | $0.00 | +3,456 | 53.6K | +7% | $0 |
| D | 2025-03-14 | 2025-03-14 | BVS | CHURCH KATRINA J | SVP, CCO | M - OptEx | $0.00 | -3,456 | 3,455 | -50% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2025-03-14 | M | A | 3,456 | $0.00 | 53,558 | D | — | — | |
| 2 | Derivative | Restricted Stock Units | 2025-03-14 | M | D | 3,456 | $0.00 | 3,455 | D | — · — to — | 3,456 Class A Common Stock | (F1) Each restricted stock unit ("RSU") represents a contingent right to receive one share of Class A common stock. (F2) The original grant of 13,823 RSUs vest in four approximately equal annual installments beginning on March 14, 2023. |